3-iodobenzylguanidine has been researched along with docetaxel anhydrous in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellersen, L; Bulten, BF; de Geus-Oei, LF; Kapusta, L; Mavinkurve-Groothuis, AM; Oyen, WJ; Sabaté-Llobera, A; van Laarhoven, HW; Verberne, HJ | 1 |
1 other study(ies) available for 3-iodobenzylguanidine and docetaxel anhydrous
| Article | Year |
|---|---|
Relationship of promising methods in the detection of anthracycline-induced cardiotoxicity in breast cancer patients.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Blood Glucose; Blood Proteins; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Docetaxel; Doxorubicin; Echocardiography; Female; Follow-Up Studies; Heart Diseases; Humans; Iodine Radioisotopes; Lipids; Middle Aged; Neoadjuvant Therapy; Observer Variation; Radiopharmaceuticals; Radiotherapy, Adjuvant; Reproducibility of Results; Risk Factors; Taxoids; Tomography, Emission-Computed, Single-Photon | 2015 |